Pharma Journalist 8791 posts 0 comments

Pfizer Inc. announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Mass. Pfizer’s Andover site houses commercial manufacturing and product development…
Read More...

Armata Pharmaceuticals announced that the previously-announced merger between C3J Therapeutics, Inc. and AmpliPhi Biosciences Corporation has closed. The new combined company, known as…
Read More...

We are delighted to share three exclusive interviews with Roche, BioTekPro and Sutro Biopharma who will be speaking at the highly anticipated Pharmaceutical Microbiology West Coast…
Read More...

SMi Reports: Registration is now open for the Orphan Drugs & Rare Diseases Conference, taking place in London, UK, this October. The market for rare disease products is…
Read More...

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation, has enrolled its first patient in the pivotal clinical study of…
Read More...

Sartorius Stedim Biotech (SSB) announced the new SIMCA 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics. The updated SIMCA…
Read More...

Pfizer announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare…
Read More...

Akcea Therapeutics and Ionis Pharmaceuticals announced that WAYLIVRA has received conditional marketing authorization from the European Commission (EC) as an adjunct to diet in adult…
Read More...

Novartis announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscuss. The tool aims to support and…
Read More...

Merck, known as MSD outside the United States and Canada, announced the presentation of results of a Phase 3 trial evaluating the efficacy and safety of BELSOMRA (suvorexant) C-IV for…
Read More...